Mipomersen Sodium
CAS 1000120-98-8 2 FDA-DMF suppliersNucleotide
Overview
Mipomersen Sodium is an antisense oligonucleotide inhibitor designed to reduce low-density lipoprotein (LDL) cholesterol levels. It achieves this by inhibiting the synthesis of apolipoprotein B-100, which is a core component of LDL and very low-density lipoprotein (VLDL).
Therapeutic areas
CardiovascularLipid metabolism disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.